Sana Biotechnology, Inc. (SANA) stock
SANANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.85−0.03 (-1.60%)
Close on Nov 18, 2026Market cap $553.82MP/E –Yield –
Sana Biotechnology cash
Cash and short-term investments held at the end of each period.
Sana Biotechnology's cash was $160.49M at Jun 30, 2026. For fiscal 2025 it was $138.38M, down 11.5% from the year before. The highest annual figure on record is $559.82M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $138.38M | -11.5% |
| FY2024 | Dec 31, 2024 | $156.33M | -23.8% |
| FY2023 | Dec 31, 2023 | $205.20M | -52.8% |
| FY2022 | Dec 31, 2022 | $434.47M | -22.4% |
| FY2021 | Dec 31, 2021 | $559.82M | +47.2% |
| FY2020 | Dec 31, 2020 | $380.41M | +365.0% |
| FY2019 | Dec 31, 2019 | $81.81M | +160.2% |
| FY2018 | Dec 31, 2018 | $31.45M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $160.49M | +108.8% |
| Q1 FY2026 | Mar 31, 2026 | $101.14M | -7.1% |
| Q4 FY2025 | Dec 31, 2025 | $138.38M | -11.5% |
| Q3 FY2025 | Sep 30, 2025 | $153.05M | -24.5% |
| Q2 FY2025 | Jun 30, 2025 | $76.87M | -69.9% |
| Q1 FY2025 | Mar 31, 2025 | $108.90M | -65.4% |
| Q4 FY2024 | Dec 31, 2024 | $156.33M | -23.8% |
| Q3 FY2024 | Sep 30, 2024 | $202.84M | -25.5% |
| Q2 FY2024 | Jun 30, 2024 | $255.48M | -24.1% |
| Q1 FY2024 | Mar 31, 2024 | $314.91M | -12.5% |
| Q4 FY2023 | Dec 31, 2023 | $205.20M | -52.8% |
| Q3 FY2023 | Sep 30, 2023 | $272.40M | -45.1% |
| Q2 FY2023 | Jun 30, 2023 | $336.42M | -32.1% |
| Q1 FY2023 | Mar 31, 2023 | $359.81M | -31.0% |
| Q4 FY2022 | Dec 31, 2022 | $434.47M | -22.4% |
| Q3 FY2022 | Sep 30, 2022 | $496.26M | -19.0% |
| Q2 FY2022 | Jun 30, 2022 | $495.31M | -42.1% |
| Q1 FY2022 | Mar 31, 2022 | $521.20M | -45.8% |
| Q4 FY2021 | Dec 31, 2021 | $559.82M | +47.2% |
| Q3 FY2021 | Sep 30, 2021 | $612.53M | +304.7% |
| Q2 FY2021 | Jun 30, 2021 | $854.98M | +87.0% |
| Q1 FY2021 | Mar 31, 2021 | $962.38M | +952.4% |
| Q4 FY2020 | Dec 31, 2020 | $380.41M | +365.0% |
| Q3 FY2020 | Sep 30, 2020 | $151.36M | +381.3% |
| Q2 FY2020 | Jun 30, 2020 | $457.18M | – |
| Q1 FY2020 | Mar 31, 2020 | $91.44M | – |
| Q4 FY2019 | Dec 31, 2019 | $81.81M | – |
| Q4 FY2018 | Dec 31, 2018 | $31.45M | – |
See a number that looks wrong?